Update in pharmacological management of coronary no-reflow phenomenon.
about
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsPaeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-ReflowSlow-flow phenomenon after elective percutaneous coronary intervention of computed tomography-detected vulnerable coronary lesion.Improving Cerebral Blood Flow after Arterial Recanalization: A Novel Therapeutic Strategy in Stroke.Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.Effect of Different Methods of Administration of Diltiazem on Clinical Efficacy in Patients with Acute ST-Segment Elevation Myocardial Infarction
P2860
Update in pharmacological management of coronary no-reflow phenomenon.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update in pharmacological management of coronary no-reflow phenomenon.
@en
type
label
Update in pharmacological management of coronary no-reflow phenomenon.
@en
prefLabel
Update in pharmacological management of coronary no-reflow phenomenon.
@en
P2093
P50
P1476
Update in pharmacological management of coronary no-reflow phenomenon
@en
P2093
Angel Sanchez-Recalde
Gabriel Trucco
Guillermo Galeote
Jose Lopez-Sendon
Luis Calvo
Santiago Jimenez-Valero
Sebastian Carrizo
P304
P356
10.2174/187152512802651024
P577
2012-09-01T00:00:00Z